Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.30 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11371842 | 0.91 | TSHR (0.40) | ALDH1A1GAATSHRTDP1NPSR1 | |
| SCHEMBL6545008 | 0.83 | ALDH1A1 (0.36) | ALDH1A1GAATSHRTDP1NPSR1 | |
| SCHEMBL6545242 | 0.79 | KDM4E (0.41) | ALDH1A1GAATSHRMAPT | |
| SCHEMBL31088807 | 0.77 | GAA (0.40) | ALDH1A1GAA | |
| SCHEMBL3394048 | 0.75 | ALDH1A1 (0.51) | ALDH1A1GAATSHRTDP1NPSR1 | |
| SCHEMBL939773 | 0.75 | ALDH1A1 (0.47) | ALDH1A1GAATSHRCYP2C19SMN1; SMN2 | |
| SCHEMBL6545234 | 0.75 | CYP3A4 (0.35) | ALDH1A1GAATSHRNPSR1CYP3A4 | |
| SCHEMBL28567972 | 0.75 | CYP3A4 (0.35) | ALDH1A1GAATSHRNPSR1CYP3A4 | |
| Hydrochloric Acid SCHEMBL612325 | 0.74 | ALDH1A1 (0.50) | ALDH1A1GAATSHRTDP1NPSR1 | |
| SCHEMBL9341642 | 0.74 | ALDH1A1 (0.37) | ALDH1A1GAATSHRTDP1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063994-A1 | Process for the preparation of cyclic amino acids | SOLCHEM ITALIANA S.P.A. (IT) | 2004-04-01 | — | — | US | disclosed |
| EP-1373186-A1 | A PROCESS FOR THE PREPARATION OF CYCLIC AMINO ACIDS | Solchem Italiana S.p.A (IT) | 2004-01-02 | — | — | EP | disclosed |
| WO-2002074727-A1 | A PROCESS FOR THE PREPARATION OF CYCLIC AMINO ACIDS | SOLCHEM ITALIANA S.P.A. (IT) | 2002-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063994-A1 | Process for the preparation of cyclic amino acids | SLC7A1, MRPL21, BCAT1 | ALDH1A1 2987/4885GAA 2650/4885TSHR 2582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.